Jeff  Abraham

Jeff Abraham

CEO of Absorption Pharmaceuticals. Promescent was introduced to the marketplace in 2011 and it has rapidly been adopted by the medical community as the first option for treating premature ejaculation as well as men wanting to extend their ejaculation latency time. Promescent has been featured on Dr. Oz, the Chicago Sun Times, and CNN and more.